Every report the desk has filed, searchable by full text, topic, format, symbol and date range.
The company's FY26 results beat revenue guidance, with new products driving the margin expansion, according to its earnings call and slide deck.
Clover's FY26 revenue topped guidance and margins surged to 35.5% in its record H2 2026, driven by new product lines.
Executives at small companies like Neonc Technologies and Solidion Technology bought modest stakes even as insiders at Delek US Holdings, Palvella Therapeutics and Dropbox sold larger blocks.
A batch of insider filings shows small-company executives making modest purchases while insiders at larger, better-known firms executed sales ranging from hundreds of thousands to over $4 million.
Filings from Schwab, Red Rock Resorts, Spyre Therapeutics and Global Industrial show a cluster of multi-million-dollar executive dispositions, with only isolated buying activity to offset the tape.
A dense batch of Form 4 disclosures over the past 24 hours points to broad-based insider distribution across financials, gaming, healthcare and industrials — a classic late-cycle signature that institutional desks watch for confirmation of stretched valuations.